Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | COMPUTER SCIENCE, THEORY & METHODS//COMPUTER SCIENCE, INFORMATION SYSTEMS//COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE | 1181119 |
23 | 3 | STATISTICS & PROBABILITY//STAT//COMMUNICATIONS IN STATISTICS-THEORY AND METHODS | 119395 |
726 | 2 | STATISTICS & PROBABILITY//STATISTICS IN MEDICINE//MULTIPLE IMPUTATION | 13119 |
36922 | 1 | CLINICAL EVENTS COMMITTEE//ENDPOINT ADJUDICATION//EVENT ADJUDICATION | 91 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CLINICAL EVENTS COMMITTEE | authKW | 1385367 | 4% | 100% | 4 |
2 | ENDPOINT ADJUDICATION | authKW | 1236932 | 5% | 71% | 5 |
3 | EVENT ADJUDICATION | authKW | 1039025 | 3% | 100% | 3 |
4 | OUTCOME ADJUDICATION | authKW | 1039025 | 3% | 100% | 3 |
5 | CLINICAL TRIAL MANAGEMENT SYSTEM | authKW | 692683 | 2% | 100% | 2 |
6 | ENDPOINT COMMITTEE | authKW | 461788 | 2% | 67% | 2 |
7 | LOGRANK STATISTIC | authKW | 445293 | 3% | 43% | 3 |
8 | CENTRAL ADJUDICATION COMMITTEES | authKW | 346342 | 1% | 100% | 1 |
9 | CENTRAL ASSESSOR | authKW | 346342 | 1% | 100% | 1 |
10 | CLINICAL EVENT CLASSIFICATION | authKW | 346342 | 1% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Statistics & Probability | 651 | 21% | 0% | 19 |
2 | Cardiac & Cardiovascular System | 327 | 24% | 0% | 22 |
3 | Medicine, Research & Experimental | 326 | 23% | 0% | 21 |
4 | Mathematical & Computational Biology | 309 | 11% | 0% | 10 |
5 | Health Care Sciences & Services | 104 | 8% | 0% | 7 |
6 | Public, Environmental & Occupational Health | 78 | 13% | 0% | 12 |
7 | Medical Informatics | 59 | 3% | 0% | 3 |
8 | Biology | 40 | 7% | 0% | 6 |
9 | Pharmacology & Pharmacy | 39 | 14% | 0% | 13 |
10 | Peripheral Vascular Diseases | 37 | 7% | 0% | 6 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HOP EUROPEEN GEORGES POMPIDOUINSERMUMRS 872 | 346342 | 1% | 100% | 1 |
2 | HPGRC UPMC BIOSFAST | 346342 | 1% | 100% | 1 |
3 | HPSERV PNEUMOLINSERMUMRS 999 | 346342 | 1% | 100% | 1 |
4 | HPSORBONNE PARIS CITE RECH CORDELIERS | 346342 | 1% | 100% | 1 |
5 | MED ANESTHESIOLAXE TRAUMATOL URGENCE SOIN | 346342 | 1% | 100% | 1 |
6 | NHS GREATER GLASGOW CLYDE PHARMACOVIGILANCE OFF | 346342 | 1% | 100% | 1 |
7 | RECH FRQS HOSP AFFILIE UNIV QUEBEC | 346342 | 1% | 100% | 1 |
8 | SCOTTISH STROKE NETWORK | 346342 | 1% | 100% | 1 |
9 | SORBONNE PARIS CITESERV PNEUMOLINSERMUMRS 970 | 346342 | 1% | 100% | 1 |
10 | URGENCESINSERMUMRS 1166IHUC ICAN | 346342 | 1% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE | 21986 | 2% | 3% | 2 |
2 | CLINICAL TRIALS | 21577 | 8% | 1% | 7 |
3 | CONTEMPORARY CLINICAL TRIALS | 5860 | 5% | 0% | 5 |
4 | TRIALS | 3758 | 7% | 0% | 6 |
5 | AMERICAN HEART JOURNAL | 1941 | 10% | 0% | 9 |
6 | JOURNAL OF CLINICAL EPIDEMIOLOGY | 1812 | 5% | 0% | 5 |
7 | JAMA CARDIOLOGY | 1765 | 1% | 1% | 1 |
8 | JOURNAL OF BIOPHARMACEUTICAL STATISTICS | 1427 | 2% | 0% | 2 |
9 | CONTROLLED CLINICAL TRIALS | 1424 | 2% | 0% | 2 |
10 | INTERNATIONAL JOURNAL OF BIOSTATISTICS | 1335 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |